$ARVN Presents Preclinical Data on Protein Degrader ARV471 at the SABCS18 httpsglobenewswire.comnewsrelease2018120816640370enArvinasPresentsPreclinicalDataonProteinDegraderARV471atthe2018SanAntonioBreastCancerSymposiumSABC

$ARVN Presents Preclinical Data on Protein Degrader, ARV-471, at the #SABCS18 https://globenewswire.com/news-release/2018/12/08/1664037/0/en/Arvinas-Presents-Preclinical-Data-on-Protein-Degrader-ARV-471-at-the-2018-San-Antonio-Breast-Cancer-Symposium-SABC

09:03 EST 8 Dec 2018 | Odi Bruckman

$ARVN Presents Preclinical Data on Protein Degrader, ARV-471, at the #SABCS18 https://globenewswire.com/news-release/2018/12/08/1664037/0/en/Arvinas-Presents-Preclinical-Data-on-Protein-Degrader-ARV-471-at-the-2018-San-Antonio-Breast-Cancer-Symposium-SABCS.html …

More From BioPortfolio on "$ARVN Presents Preclinical Data on Protein Degrader, ARV-471, at the #SABCS18 https://globenewswire.com/news-release/2018/12/08/1664037/0/en/Arvinas-Presents-Preclinical-Data-on-Protein-Degrader-ARV-471-at-the-2018-San-Antonio-Breast-Cancer-Symposium-SABC"